Suppr超能文献

测定药物的游离浓度和蛋白结合率所面临的生物分析挑战。

The bioanalytical challenge of determining unbound concentration and protein binding for drugs.

作者信息

Nilsson Lars B

机构信息

Analytical Pharmaceutical Chemistry, Dept. of Medicinal Chemistry, Uppsala University, BMC Box 574, SE-75123 Uppsala, Sweden.

出版信息

Bioanalysis. 2013 Dec;5(24):3033-50. doi: 10.4155/bio.13.274.

Abstract

Knowledge regarding unbound concentrations is of vital importance when exploring the PK and PD of a drug. The accurate and reproducible determination of plasma protein binding and unbound concentrations for a compound/drug is a serious challenge for the bioanalytical laboratory. When the drug is in equilibrium with the binding protein(s), this equilibrium will shift when physiological conditions are not met. Furthermore, the true unbound fraction/concentration is unknown, and there are numerous publications in the scientific literature reporting and discussing data that have been produced without sufficient control of the parameters influencing the equilibrium. In this Review, different parameters affecting the equilibrium and analysis are discussed, together with suggestions on how to control these parameters in order to produce as trustworthy results for unbound concentrations/fractions as possible.

摘要

在探究药物的药代动力学和药效学过程中,关于游离浓度的知识至关重要。准确且可重复地测定化合物/药物的血浆蛋白结合率和游离浓度,对生物分析实验室而言是一项严峻挑战。当药物与结合蛋白处于平衡状态时,若生理条件未满足,这种平衡将会发生改变。此外,真实的游离分数/浓度是未知的,科学文献中有大量出版物报道并讨论了在未充分控制影响平衡的参数情况下所产生的数据。在本综述中,我们讨论了影响平衡和分析的不同参数,以及关于如何控制这些参数的建议,以便尽可能获得关于游离浓度/分数的可靠结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验